| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B CACNB2 SHROOM3 SPIRE2 MTUS1 SYNE1 SVIL MID1 KIF19 TRIOBP STMND1 SORBS1 FHDC1 CCDC61 | 9.35e-05 | 1099 | 79 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule binding | 2.18e-04 | 308 | 79 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 2.88e-04 | 428 | 79 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 4.26e-04 | 8 | 79 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | actin binding | 6.08e-04 | 479 | 79 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.12e-04 | 42 | 79 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 1.16e-03 | 199 | 79 | 5 | GO:1901981 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.28e-03 | 54 | 79 | 3 | GO:0030159 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CDKL5 SHROOM3 NEO1 HEG1 CELSR3 RNF6 DSCAM SYNE1 PLXNA4 TRIOBP RIMS1 CTNND2 RIMS2 PIP5K1C NEUROG3 | 4.78e-05 | 1194 | 80 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CDKL5 NEO1 CELSR3 RNF6 DSCAM SYNE1 PLXNA4 RIMS1 CTNND2 RIMS2 PIP5K1C NEUROG3 | 5.84e-05 | 802 | 80 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CDKL5 NEO1 CELSR3 RNF6 DSCAM SYNE1 PLXNA4 RIMS1 CTNND2 RIMS2 PIP5K1C NEUROG3 | 7.13e-05 | 819 | 80 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CDKL5 NEO1 CELSR3 RNF6 DSCAM SYNE1 PLXNA4 RIMS1 CTNND2 RIMS2 PIP5K1C NEUROG3 | 7.73e-05 | 826 | 80 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | synaptic signaling | CDKL5 CACNB2 NEO1 INSYN1 KCNH1 SYNE1 KMT2A SORBS1 RIMS1 CTNND2 RIMS2 PIP5K1C SYT10 | 9.11e-05 | 976 | 80 | 13 | GO:0099536 |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 1.22e-04 | 25 | 80 | 3 | GO:0048791 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.26e-04 | 125 | 80 | 5 | GO:0016079 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CDKL5 NEO1 CELSR3 RNF6 DSCAM SYNE1 PLXNA4 TRIOBP CTNND2 PIP5K1C NEUROG3 | 1.42e-04 | 748 | 80 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 1.54e-04 | 27 | 80 | 3 | GO:0060080 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.54e-04 | 207 | 80 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CDKL5 CACNB2 NEO1 INSYN1 KCNH1 SYNE1 KMT2A RIMS1 CTNND2 RIMS2 PIP5K1C SYT10 | 2.37e-04 | 931 | 80 | 12 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CDKL5 CACNB2 NEO1 INSYN1 KCNH1 SYNE1 KMT2A RIMS1 CTNND2 RIMS2 PIP5K1C SYT10 | 2.37e-04 | 931 | 80 | 12 | GO:0007268 |
| GeneOntologyBiologicalProcess | protein depolymerization | 2.44e-04 | 144 | 80 | 5 | GO:0051261 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CDKL5 CACNB2 NEO1 INSYN1 KCNH1 SYNE1 KMT2A RIMS1 CTNND2 RIMS2 PIP5K1C SYT10 | 2.56e-04 | 939 | 80 | 12 | GO:0099537 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SHROOM3 SPIRE2 RIPK3 SVIL MID1 KIF19 TRIOBP PRKCD STMND1 SORBS1 FHDC1 CCDC57 | 3.04e-04 | 957 | 80 | 12 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 3.08e-04 | 7 | 80 | 2 | GO:0150037 | |
| GeneOntologyBiologicalProcess | neuron projection development | CDKL5 NEO1 CELSR3 RNF6 DSCAM SYNE1 PLXNA4 TRIOBP STMND1 RIMS1 CTNND2 RIMS2 PIP5K1C NEUROG3 | 3.88e-04 | 1285 | 80 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of insulin receptor signaling pathway | 4.52e-04 | 92 | 80 | 4 | GO:0046626 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 4.57e-04 | 165 | 80 | 5 | GO:1903305 | |
| GeneOntologyBiologicalProcess | cilium organization | 5.14e-04 | 476 | 80 | 8 | GO:0044782 | |
| GeneOntologyCellularComponent | asymmetric synapse | 8.59e-05 | 477 | 80 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.72e-04 | 523 | 80 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | microtubule organizing center | CDKL5 MTUS1 MID1 TRIOBP MARCHF7 IRS1 SORBS1 TOPORS CCDC57 CCDC61 LUZP1 SMTNL2 | 1.86e-04 | 919 | 80 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | postsynaptic density | 3.29e-04 | 451 | 80 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 3.99e-04 | 8 | 80 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | postsynapse | KIF21B CDKL5 NEO1 CELSR3 INSYN1 KCNH1 SYNE1 EIF4G1 PRKCD RIMS1 CTNND2 PIP5K1C | 4.71e-04 | 1018 | 80 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | 6.76e-04 | 503 | 80 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | microtubule | 9.83e-04 | 533 | 80 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | glutamatergic synapse | KIF21B CDKL5 NEO1 CELSR3 PLXNA4 RIMS1 CTNND2 RIMS2 PIP5K1C SYT10 | 1.09e-03 | 817 | 80 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 1.28e-03 | 14 | 80 | 2 | GO:0099569 | |
| Domain | - | SPIRE2 RNF6 MID1 RLIM KMT2A MARCHF7 SCAF11 RIMS1 TOPORS RIMS2 DNMT3B | 2.20e-06 | 449 | 77 | 11 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | SPIRE2 RNF6 MID1 RLIM KMT2A MARCHF7 SCAF11 RIMS1 TOPORS RIMS2 DNMT3B | 2.72e-06 | 459 | 77 | 11 | IPR013083 |
| Domain | MA3 | 2.49e-04 | 6 | 77 | 2 | SM00544 | |
| Domain | MA3 | 2.49e-04 | 6 | 77 | 2 | PF02847 | |
| Domain | MI | 2.49e-04 | 6 | 77 | 2 | PS51366 | |
| Domain | Initiation_fac_eIF4g_MI | 2.49e-04 | 6 | 77 | 2 | IPR003891 | |
| Domain | C2 | 2.55e-04 | 137 | 77 | 5 | SM00239 | |
| Domain | C2 | 3.01e-04 | 142 | 77 | 5 | PS50004 | |
| Domain | Znf_FYVE_PHD | 3.53e-04 | 147 | 77 | 5 | IPR011011 | |
| Domain | - | 3.65e-04 | 148 | 77 | 5 | 2.60.40.150 | |
| Domain | C2_dom | 5.83e-04 | 164 | 77 | 5 | IPR000008 | |
| Domain | MIF4G | 7.39e-04 | 10 | 77 | 2 | SM00543 | |
| Domain | MIF4G | 7.39e-04 | 10 | 77 | 2 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 7.39e-04 | 10 | 77 | 2 | IPR003890 | |
| Domain | FYVE_2 | 9.01e-04 | 11 | 77 | 2 | PF02318 | |
| Domain | FN3 | 1.00e-03 | 185 | 77 | 5 | SM00060 | |
| Domain | PH | 1.01e-03 | 278 | 77 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 1.03e-03 | 279 | 77 | 6 | PS50003 | |
| Domain | PH_domain | 1.05e-03 | 280 | 77 | 6 | IPR001849 | |
| Domain | RABBD | 1.08e-03 | 12 | 77 | 2 | PS50916 | |
| Domain | Rab_BD | 1.08e-03 | 12 | 77 | 2 | IPR010911 | |
| Domain | zf-RING_2 | 1.29e-03 | 52 | 77 | 3 | PF13639 | |
| Domain | FN3 | 1.39e-03 | 199 | 77 | 5 | PS50853 | |
| Domain | MIF4-like | 1.70e-03 | 15 | 77 | 2 | IPR016021 | |
| Domain | - | 1.70e-03 | 15 | 77 | 2 | 1.25.40.180 | |
| Domain | FN3_dom | 1.72e-03 | 209 | 77 | 5 | IPR003961 | |
| Domain | C2 | 2.11e-03 | 131 | 77 | 4 | PF00168 | |
| Domain | Znf_RING | 2.26e-03 | 326 | 77 | 6 | IPR001841 | |
| Domain | zf-C3HC4 | 2.28e-03 | 223 | 77 | 5 | PF00097 | |
| Domain | PDZ | 2.75e-03 | 141 | 77 | 4 | PF00595 | |
| Domain | PDZ | 3.27e-03 | 148 | 77 | 4 | SM00228 | |
| Domain | - | 3.43e-03 | 150 | 77 | 4 | 2.30.42.10 | |
| Domain | PDZ | 3.52e-03 | 151 | 77 | 4 | PS50106 | |
| Domain | PDZ | 3.60e-03 | 152 | 77 | 4 | IPR001478 | |
| Domain | PWWP | 4.01e-03 | 23 | 77 | 2 | PF00855 | |
| Domain | PWWP_dom | 4.01e-03 | 23 | 77 | 2 | IPR000313 | |
| Domain | PWWP | 4.37e-03 | 24 | 77 | 2 | PS50812 | |
| Domain | fn3 | 4.52e-03 | 162 | 77 | 4 | PF00041 | |
| Domain | - | 5.51e-03 | 391 | 77 | 6 | 2.30.29.30 | |
| Domain | Znf_C3HC4_RING-type | 5.58e-03 | 172 | 77 | 4 | IPR018957 | |
| Domain | ZF_RING_1 | 7.03e-03 | 291 | 77 | 5 | PS00518 | |
| Domain | ZF_RING_2 | 7.75e-03 | 298 | 77 | 5 | PS50089 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP31 SHROOM3 SPIRE2 MTUS1 SVIL CNKSR3 EIF4G1 SPATA18 KMT2A IRS1 SORBS1 LARP1B SRRM2 RASAL2 LUZP1 GAB2 | 1.07e-10 | 861 | 80 | 16 | 36931259 |
| Pubmed | KIF21B CACNB2 SHROOM3 DSCAM SYNE1 SVIL CNKSR3 EIF4G1 TRIOBP SORBS1 RIMS1 CTNND2 AFF4 RASAL2 LUZP1 | 4.80e-09 | 963 | 80 | 15 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KANSL1 SGTA SVIL EIF4G1 USP24 MKI67 KMT2A ACIN1 PRKCD SCAF11 RIMS1 TOPORS SRRM2 | 2.38e-08 | 774 | 80 | 13 | 15302935 |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 37770450 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.88e-07 | 281 | 80 | 8 | 28706196 | |
| Pubmed | 4.21e-07 | 65 | 80 | 5 | 23453885 | ||
| Pubmed | NFE2L3 SARS2 CELSR3 DSCAM RBL2 SYNE1 SGTA EIF4G1 TRIOBP ASTN2 SORBS1 CTNND2 AFF4 RASAL2 | 1.27e-06 | 1285 | 80 | 14 | 35914814 | |
| Pubmed | KIF21B SHROOM3 CELSR3 MTUS1 TRIOBP FNDC3A SCAF11 RIMS2 CWC22 | 3.62e-06 | 529 | 80 | 9 | 14621295 | |
| Pubmed | 4.16e-06 | 103 | 80 | 5 | 10574462 | ||
| Pubmed | USP31 CDKL5 CACNB2 SYNE1 SVIL EIF4G1 SCAPER PLXNA4 KMT2A SORBS1 RIMS1 CTNND2 RASAL2 LUZP1 | 4.43e-06 | 1431 | 80 | 14 | 37142655 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15516986 | ||
| Pubmed | RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction. | 5.23e-06 | 2 | 80 | 2 | 25240052 | |
| Pubmed | Analysis of RIM Expression and Function at Mouse Photoreceptor Ribbon Synapses. | 5.23e-06 | 2 | 80 | 2 | 28701482 | |
| Pubmed | RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes. | 5.23e-06 | 2 | 80 | 2 | 29606581 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26400943 | ||
| Pubmed | A presynaptic phosphosignaling hub for lasting homeostatic plasticity. | 5.23e-06 | 2 | 80 | 2 | 35443170 | |
| Pubmed | Recent ultra-rare inherited variants implicate new autism candidate risk genes. | 5.23e-06 | 2 | 80 | 2 | 34312540 | |
| Pubmed | Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta. | 5.23e-06 | 2 | 80 | 2 | 14583092 | |
| Pubmed | RIM genes differentially contribute to organizing presynaptic release sites. | 5.23e-06 | 2 | 80 | 2 | 22753485 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 25563840 | ||
| Pubmed | The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus. | 5.23e-06 | 2 | 80 | 2 | 22956829 | |
| Pubmed | 1.20e-05 | 128 | 80 | 5 | 30995482 | ||
| Pubmed | 1.39e-05 | 63 | 80 | 4 | 25053427 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 27163153 | ||
| Pubmed | RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone. | 1.57e-05 | 3 | 80 | 2 | 21262468 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 26034270 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 28377503 | ||
| Pubmed | RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. | 1.57e-05 | 3 | 80 | 2 | 21241895 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 18285345 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 25343783 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 31486769 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 25730884 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 15330860 | ||
| Pubmed | The ubiquitin ligase Rnf6 regulates local LIM kinase 1 levels in axonal growth cones. | 1.57e-05 | 3 | 80 | 2 | 16204183 | |
| Pubmed | Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex. | 1.57e-05 | 3 | 80 | 2 | 25155955 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 10588740 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.60e-05 | 231 | 80 | 6 | 16452087 | |
| Pubmed | 1.78e-05 | 67 | 80 | 4 | 29254152 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.03e-05 | 361 | 80 | 7 | 30344098 | |
| Pubmed | 3.09e-05 | 77 | 80 | 4 | 29445148 | ||
| Pubmed | Protein composition of axonal dopamine release sites in the striatum. | 3.13e-05 | 4 | 80 | 2 | 36579890 | |
| Pubmed | Divergent properties and independent regulation of striatal dopamine and GABA co-transmission. | 3.13e-05 | 4 | 80 | 2 | 35584679 | |
| Pubmed | RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13. | 3.13e-05 | 4 | 80 | 2 | 21262469 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 12620390 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 12874135 | ||
| Pubmed | Recurrent CNVs disrupt three candidate genes in schizophrenia patients. | 3.13e-05 | 4 | 80 | 2 | 18940311 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 20452978 | ||
| Pubmed | Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). | 3.13e-05 | 4 | 80 | 2 | 15364919 | |
| Pubmed | Fusion Competent Synaptic Vesicles Persist upon Active Zone Disruption and Loss of Vesicle Docking. | 3.13e-05 | 4 | 80 | 2 | 27537483 | |
| Pubmed | Genetic mapping of eight SH3 domain genes on seven mouse chromosomes. | 3.68e-05 | 28 | 80 | 3 | 10087302 | |
| Pubmed | 4.35e-05 | 407 | 80 | 7 | 12693553 | ||
| Pubmed | 4.55e-05 | 30 | 80 | 3 | 17257418 | ||
| Pubmed | 4.99e-05 | 283 | 80 | 6 | 21903422 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 12871946 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 28607399 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 32755572 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 22553025 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 5.20e-05 | 5 | 80 | 2 | 33139401 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 11438522 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 12031982 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 33539324 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 5.20e-05 | 5 | 80 | 2 | 34706221 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 28425913 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 22248876 | ||
| Pubmed | Planar cell polarity controls pancreatic beta cell differentiation and glucose homeostasis. | 5.54e-05 | 32 | 80 | 3 | 23177622 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EIF4G1 MKI67 KMT2A ACIN1 SCAF11 FANCM SRRM2 CWC22 AFF4 LUZP1 | 6.68e-05 | 954 | 80 | 10 | 36373674 |
| Pubmed | 7.46e-05 | 777 | 80 | 9 | 35844135 | ||
| Pubmed | cAMP-GEFII is a direct target of cAMP in regulated exocytosis. | 7.79e-05 | 6 | 80 | 2 | 11056535 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 17786244 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 17567962 | ||
| Pubmed | The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators. | 7.79e-05 | 6 | 80 | 2 | 31679900 | |
| Pubmed | Genetic analysis of DSCAM's role as a Netrin-1 receptor in vertebrates. | 7.79e-05 | 6 | 80 | 2 | 22238077 | |
| Pubmed | How to Make an Active Zone: Unexpected Universal Functional Redundancy between RIMs and RIM-BPs. | 7.79e-05 | 6 | 80 | 2 | 27537484 | |
| Pubmed | 8.94e-05 | 101 | 80 | 4 | 18519826 | ||
| Pubmed | 9.65e-05 | 103 | 80 | 4 | 32744500 | ||
| Pubmed | NFE2L3 CACNB2 DSCAM ASTN2 SORBS1 FHDC1 ARHGEF3 NAALADL2 RASAL2 | 1.06e-04 | 814 | 80 | 9 | 23251661 | |
| Pubmed | 1.06e-04 | 202 | 80 | 5 | 24639526 | ||
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.09e-04 | 7 | 80 | 2 | 36398873 | |
| Pubmed | Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites. | 1.09e-04 | 7 | 80 | 2 | 29398114 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.09e-04 | 7 | 80 | 2 | 35176221 | |
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 24114270 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 20448145 | ||
| Pubmed | NFE2L3 SYNE1 CNKSR3 EIF4G1 PLXNA4 KMT2A ACIN1 RIMS1 RIMS2 CCDC57 LUZP1 DNMT3B | 1.09e-04 | 1442 | 80 | 12 | 35575683 | |
| Pubmed | 1.26e-04 | 42 | 80 | 3 | 35705031 | ||
| Pubmed | RNF6 SVIL EIF4G1 MKI67 ACIN1 IRS1 TOPORS SRRM2 MTPAP AFF4 LUZP1 | 1.31e-04 | 1247 | 80 | 11 | 27684187 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.39e-04 | 341 | 80 | 6 | 32971831 | |
| Pubmed | 1.41e-04 | 660 | 80 | 8 | 32780723 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 15068794 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 22905720 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 19882138 | ||
| Pubmed | REST is a major negative regulator of endocrine differentiation during pancreas organogenesis. | 1.45e-04 | 8 | 80 | 2 | 34385258 | |
| Pubmed | USP31 SHROOM3 NEO1 SARS2 SYNE1 SGTA TRIOBP FNDC3A SRRM2 CCDC61 RASAL2 LRRC41 | 1.46e-04 | 1487 | 80 | 12 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNB2 SHROOM3 SGTA TRIOBP ASTN2 SCAF11 RIMS1 TAFA5 CCDC57 NAALADL2 AFF4 LRRC41 | 1.48e-04 | 1489 | 80 | 12 | 28611215 |
| Pubmed | 1.63e-04 | 118 | 80 | 4 | 30979931 | ||
| Pubmed | 1.86e-04 | 360 | 80 | 6 | 33111431 | ||
| Pubmed | MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. | 1.86e-04 | 9 | 80 | 2 | 16443760 | |
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 31519700 | ||
| Pubmed | Expression analysis of the Islet-1 gene in the developing and adult gastrointestinal tract. | 1.86e-04 | 9 | 80 | 2 | 21220053 | |
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 22586265 | ||
| Pubmed | 1.94e-04 | 230 | 80 | 5 | 29513927 | ||
| Interaction | YWHAH interactions | KIF21B USP31 SHROOM3 SPIRE2 MTUS1 RPS6KB2 SVIL CNKSR3 EIF4G1 SPATA18 KMT2A IRS1 SORBS1 RIMS1 LARP1B RIMS2 SRRM2 CWC22 RASAL2 LUZP1 GAB2 SMTNL2 | 1.80e-10 | 1102 | 80 | 22 | int:YWHAH |
| Interaction | YWHAG interactions | KIF21B USP31 SHROOM3 SPIRE2 MTUS1 SVIL CNKSR3 EIF4G1 SPATA18 USP24 KMT2A ACIN1 PRKCD SCAF11 IRS1 SORBS1 LARP1B SRRM2 CWC22 RASAL2 LUZP1 GAB2 SMTNL2 | 3.02e-10 | 1248 | 80 | 23 | int:YWHAG |
| Interaction | YWHAB interactions | KIF21B USP31 SHROOM3 SPIRE2 SGTA SVIL CNKSR3 EIF4G1 SPATA18 KMT2A PRKCD IRS1 SORBS1 SRRM2 RASAL2 LUZP1 GAB2 SMTNL2 | 6.76e-08 | 1014 | 80 | 18 | int:YWHAB |
| Interaction | SFN interactions | MAGEA1 USP31 SHROOM3 SPIRE2 MTUS1 SVIL EIF4G1 KMT2A IRS1 SORBS1 SRRM2 RASAL2 LUZP1 GAB2 SMTNL2 | 7.82e-08 | 692 | 80 | 15 | int:SFN |
| Interaction | YWHAQ interactions | KIF21B USP31 SHROOM3 SPIRE2 MTUS1 RPS6KB2 SVIL CNKSR3 EIF4G1 SPATA18 KMT2A IRS1 SORBS1 LARP1B RASAL2 LUZP1 GAB2 SMTNL2 | 2.90e-07 | 1118 | 80 | 18 | int:YWHAQ |
| Interaction | YWHAE interactions | KIF21B USP31 SHROOM3 SPIRE2 SVIL CNKSR3 SPATA18 KMT2A SCAF11 IRS1 SORBS1 RIMS2 SRRM2 RASAL2 LUZP1 GAB2 SMTNL2 | 6.95e-06 | 1256 | 80 | 17 | int:YWHAE |
| Interaction | DENND2D interactions | 1.23e-05 | 36 | 80 | 4 | int:DENND2D | |
| Interaction | YWHAZ interactions | USP31 SHROOM3 SPIRE2 MTUS1 SVIL CNKSR3 SPATA18 KMT2A PRKCD SCAF11 IRS1 SORBS1 RASAL2 LUZP1 GAB2 SMTNL2 | 5.17e-05 | 1319 | 80 | 16 | int:YWHAZ |
| Interaction | DLGAP1 interactions | 8.12e-05 | 180 | 80 | 6 | int:DLGAP1 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 5.23e-05 | 4 | 54 | 2 | 833 | |
| GeneFamily | Fibronectin type III domain containing | 1.14e-04 | 160 | 54 | 5 | 555 | |
| GeneFamily | Ring finger proteins | 1.64e-04 | 275 | 54 | 6 | 58 | |
| GeneFamily | PDZ domain containing | 1.10e-03 | 152 | 54 | 4 | 1220 | |
| GeneFamily | PWWP domain containing | 1.95e-03 | 22 | 54 | 2 | 1147 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.32e-03 | 206 | 54 | 4 | 682 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 8.33e-03 | 46 | 54 | 2 | 622 | |
| GeneFamily | Ubiquitin specific peptidases | 1.22e-02 | 56 | 54 | 2 | 366 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | CACNB2 INSYN1 RBL2 CNKSR3 TRIOBP ASTN2 FNDC3A FHDC1 CCDC57 NAALADL2 | 4.57e-07 | 407 | 80 | 10 | M2214 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.81e-06 | 300 | 80 | 8 | M8702 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RNF6 MTUS1 PWWP3A PRKCD MARCHF7 SORBS1 ARHGEF3 TOPORS MTPAP AFF4 RASAL2 DNMT3B | 7.11e-06 | 822 | 80 | 12 | M6782 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.42e-05 | 171 | 80 | 6 | M39234 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.68e-05 | 176 | 80 | 6 | M39223 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 2.39e-05 | 506 | 80 | 9 | M39067 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.28e-05 | 208 | 80 | 6 | M39233 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 7.23e-05 | 584 | 80 | 9 | M39068 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 8.33e-05 | 145 | 80 | 5 | M1810 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 9.45e-05 | 240 | 80 | 6 | M39236 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | BNC2 CACNB2 HEG1 MTUS1 RLIM EIF4G1 SCAPER PLXNA4 ACIN1 SCAF11 RIMS1 LARP1B | 2.61e-05 | 770 | 79 | 12 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | BNC2 HEG1 KANSL1 MID1 RLIM EIF4G1 ACIN1 FNDC3A SCAF11 TOPORS CCDC61 RASAL2 | 3.98e-05 | 804 | 79 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | SHROOM3 CNKSR3 EIF4G1 SCAF11 SORBS1 TAFA5 CTNND2 FANCM TOPORS RIMS2 LUZP1 SMTNL2 DNMT3B | 6.94e-05 | 991 | 79 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | BNC2 CACNB2 SHROOM3 NEO1 KCNH1 RLIM PLXNA4 MUC16 IRS1 TOPORS CWC22 GAB2 | 7.44e-05 | 858 | 79 | 12 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | BNC2 CACNB2 HEG1 KANSL1 RLIM EIF4G1 SCAPER ACIN1 SCAF11 LARP1B RASAL2 | 1.39e-04 | 778 | 79 | 11 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.50e-04 | 413 | 79 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-08 | 185 | 80 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-08 | 188 | 80 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-08 | 188 | 80 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.88e-08 | 188 | 80 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-08 | 188 | 80 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-08 | 188 | 80 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.45e-08 | 200 | 80 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-07 | 173 | 80 | 6 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-06 | 185 | 80 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-06 | 186 | 80 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-06 | 188 | 80 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 189 | 80 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.29e-06 | 192 | 80 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-06 | 195 | 80 | 6 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.59e-06 | 199 | 80 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-06 | 200 | 80 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 200 | 80 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 162 | 80 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 1.13e-05 | 163 | 80 | 5 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 171 | 80 | 5 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 171 | 80 | 5 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-05 | 172 | 80 | 5 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-05 | 172 | 80 | 5 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-05 | 172 | 80 | 5 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 173 | 80 | 5 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 177 | 80 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 177 | 80 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 179 | 80 | 5 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-05 | 179 | 80 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 181 | 80 | 5 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 183 | 80 | 5 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-05 | 183 | 80 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 184 | 80 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-05 | 184 | 80 | 5 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.09e-05 | 185 | 80 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 185 | 80 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 186 | 80 | 5 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.25e-05 | 188 | 80 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-05 | 188 | 80 | 5 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.25e-05 | 188 | 80 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.31e-05 | 189 | 80 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 189 | 80 | 5 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.31e-05 | 189 | 80 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.31e-05 | 189 | 80 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-05 | 189 | 80 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 190 | 80 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.37e-05 | 190 | 80 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.37e-05 | 190 | 80 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 190 | 80 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 191 | 80 | 5 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 191 | 80 | 5 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.43e-05 | 191 | 80 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 191 | 80 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 192 | 80 | 5 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 193 | 80 | 5 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 193 | 80 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-05 | 193 | 80 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 194 | 80 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.62e-05 | 194 | 80 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-05 | 194 | 80 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.62e-05 | 194 | 80 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.62e-05 | 194 | 80 | 5 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.62e-05 | 194 | 80 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.68e-05 | 195 | 80 | 5 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.68e-05 | 195 | 80 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-05 | 195 | 80 | 5 | 44f67437ea65d530133a0240b17f9860d9cc0e99 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.68e-05 | 195 | 80 | 5 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 2.68e-05 | 195 | 80 | 5 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-05 | 196 | 80 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-05 | 198 | 80 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.11e-05 | 127 | 80 | 4 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.03e-04 | 135 | 80 | 4 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.22e-04 | 141 | 80 | 4 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-7|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.35e-04 | 145 | 80 | 4 | 88090a226ddfa6df59976f025bf0fd84ca0f72ef | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Fos_(Layer_2/3,_IEG+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 56 | 80 | 3 | a6a0345ddb9db1441fc048bc4d7b05f625de2ccd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 153 | 80 | 4 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 156 | 80 | 4 | e6798d2b9c2c1fc6525c24f596f25aa85a375651 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 156 | 80 | 4 | c11ca6b1b5029c15aab91273cece70a487287839 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 157 | 80 | 4 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | Ciliated_cells-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-04 | 162 | 80 | 4 | 5319603f7ba3f48126dcf2ba9ae604be11bf2577 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-04 | 162 | 80 | 4 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 162 | 80 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-04 | 164 | 80 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 2.32e-04 | 167 | 80 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 80 | 4 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.38e-04 | 168 | 80 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 169 | 80 | 4 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.49e-04 | 170 | 80 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 171 | 80 | 4 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-04 | 171 | 80 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 175 | 80 | 4 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.20e-07 | 197 | 79 | 8 | 2860_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.05e-06 | 194 | 79 | 7 | 3280_DN | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.40e-06 | 196 | 79 | 7 | 982_DN | |
| Disease | Neurodevelopmental Disorders | 5.57e-06 | 93 | 80 | 5 | C1535926 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 8.34e-06 | 101 | 80 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | vesicle-fusing ATPase measurement | 2.17e-05 | 3 | 80 | 2 | EFO_0802214 | |
| Disease | alcohol consumption measurement | KANSL1 CNKSR3 EIF4G1 SCAPER PLXNA4 ASTN2 SCAF11 TAFA5 CTNND2 RIMS2 SYT10 AFF4 DNMT3B | 2.79e-05 | 1242 | 80 | 13 | EFO_0007878 |
| Disease | ovarian neoplasm | 3.28e-05 | 134 | 80 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 3.64e-05 | 137 | 80 | 5 | C1140680 | |
| Disease | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related measurement | 4.34e-05 | 4 | 80 | 2 | EFO_0803114 | |
| Disease | brain measurement, neuroimaging measurement | 1.24e-04 | 550 | 80 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | nicotine dependence symptom count | 1.27e-04 | 285 | 80 | 6 | EFO_0009262 | |
| Disease | Malignant neoplasm of breast | MAGEA1 GUCY2F KCNH1 SYNE1 RPS6KB2 SPATA18 MKI67 ASTN2 SORBS1 RASAL2 DNMT3B | 1.49e-04 | 1074 | 80 | 11 | C0006142 |
| Disease | age-related hearing impairment | 2.54e-04 | 324 | 80 | 6 | EFO_0005782 | |
| Disease | urate measurement, bone density | 2.76e-04 | 619 | 80 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | idiopathic osteonecrosis of the femoral head | 3.85e-04 | 52 | 80 | 3 | EFO_1001930 | |
| Disease | nucleus accumbens volume change measurement | 3.93e-04 | 11 | 80 | 2 | EFO_0021493 | |
| Disease | skin melanoma (is_marker_for) | 5.55e-04 | 13 | 80 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Colorectal Carcinoma | 6.34e-04 | 702 | 80 | 8 | C0009402 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.90e-04 | 152 | 80 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cortical thickness | BNC2 SHROOM3 SPIRE2 NEO1 KANSL1 CNKSR3 TRIOBP KMT2A ASTN2 LUZP1 | 8.41e-04 | 1113 | 80 | 10 | EFO_0004840 |
| Disease | coronary thrombosis, GM11992 | 8.50e-04 | 16 | 80 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | cortical surface area measurement | BNC2 SHROOM3 SPIRE2 NEO1 KANSL1 CNKSR3 TRIOBP MARCHF7 ASTN2 FAM124B LUZP1 | 9.89e-04 | 1345 | 80 | 11 | EFO_0010736 |
| Disease | caudal middle frontal gyrus volume measurement | 1.08e-03 | 18 | 80 | 2 | EFO_0010290 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.13e-03 | 75 | 80 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | diet measurement, HOMA-B | 1.20e-03 | 19 | 80 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | pulse pressure measurement | BNC2 CACNB2 SHROOM3 KANSL1 DSCAM TRIOBP CTNND2 CWC22 SYT10 LUZP1 DNMT3B | 1.30e-03 | 1392 | 80 | 11 | EFO_0005763 |
| Disease | response to heparin, antibody measurement | 1.34e-03 | 20 | 80 | 2 | EFO_0004556, EFO_0006816 | |
| Disease | hair colour measurement | 1.41e-03 | 615 | 80 | 7 | EFO_0007822 | |
| Disease | fumarate measurement | 1.47e-03 | 21 | 80 | 2 | EFO_0010480 | |
| Disease | creatinine measurement | 1.48e-03 | 995 | 80 | 9 | EFO_0004518 | |
| Disease | hemoglobin change measurement | 1.62e-03 | 22 | 80 | 2 | EFO_0600027 | |
| Disease | uterine fibroid | 2.13e-03 | 199 | 80 | 4 | EFO_0000731 | |
| Disease | reticulocyte measurement | 2.18e-03 | 1053 | 80 | 9 | EFO_0010700 | |
| Disease | triacylglycerol 48:0 measurement | 2.26e-03 | 26 | 80 | 2 | EFO_0010403 | |
| Disease | response to perphenazine | 2.26e-03 | 26 | 80 | 2 | GO_0097334 | |
| Disease | Acute monocytic leukemia | 2.26e-03 | 26 | 80 | 2 | C0023465 | |
| Disease | neuroimaging measurement | 2.41e-03 | 1069 | 80 | 9 | EFO_0004346 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 2.44e-03 | 27 | 80 | 2 | DOID:8552 (is_marker_for) | |
| Disease | lobe attachment | 2.45e-03 | 207 | 80 | 4 | EFO_0007667 | |
| Disease | Liver carcinoma | 2.57e-03 | 507 | 80 | 6 | C2239176 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.62e-03 | 28 | 80 | 2 | DOID:4194 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSVQARRLSQPESA | 701 | Q9UKV3 | |
| PNRSRNRSSSVDSFR | 401 | Q9Y6R9 | |
| TLQRSISFRSESRPD | 66 | Q9NR81 | |
| TRSESPAVRTRNNNS | 96 | Q9UBC3 | |
| PAVRTRNNNSVSSRE | 101 | Q9UBC3 | |
| DIRTFIESNNRTRSP | 281 | Q6ZN30 | |
| FVASSSTIERDRQRP | 1036 | Q9UQB3 | |
| GPQARESFRSSRLQT | 261 | O75129 | |
| RQKSPAQSDSTTQRR | 546 | Q9UHB7 | |
| DQRTDRSAPIRSASQ | 501 | Q08289 | |
| PEQTRRVTRNSSTQT | 256 | Q2T9L4 | |
| STTRRRLFVENDSPS | 676 | Q08999 | |
| RVPSFARNTVASSSR | 1031 | Q9C0D6 | |
| SNAATSPERVRNATS | 776 | Q8WXI7 | |
| TRQRQPSEGSSSREE | 71 | P43355 | |
| VQVTRETERSFPRAS | 11 | Q9Y4Z2 | |
| NSRQQTVLSRTPRSD | 546 | Q9ULD2 | |
| QRASRRSDSASSEPV | 296 | Q05655 | |
| RNTDQRSSENRRSEP | 186 | Q8TC71 | |
| RRFPINRSELSSSDE | 1456 | Q8IYD8 | |
| RRNPETSVTQSSSAQ | 96 | Q9HCG8 | |
| SEQRVPALRFNSSSV | 746 | Q9HCM2 | |
| RGSTFPRQSRATETS | 1201 | O75037 | |
| TFRRDPTARTSQSQE | 326 | Q9Y4A8 | |
| SRSRQQSSSSRESPV | 916 | Q9UJF2 | |
| TSQQPVRRRRGESSF | 846 | Q7Z3B3 | |
| RRSSQSPQELFEISR | 961 | O95259 | |
| FRRNRISSPEDISDS | 276 | Q8N8V4 | |
| PSAVESRRNSRVTGN | 376 | Q9ULI3 | |
| REQEPARRVSRSSFS | 116 | P46013 | |
| QTSERSRVRSSNQLP | 156 | Q9NVV4 | |
| DTAAQTNSRLARPTR | 846 | P35568 | |
| RLQERSRSQTPLSTA | 211 | Q86UR5 | |
| SEQSERPRGRISSFT | 1366 | Q86UR5 | |
| RTQEPTAANQTSSRS | 206 | Q2TAC6 | |
| RTTTRSRSTERPDTN | 1101 | Q9UQ26 | |
| SVSAKRTSEPRSQRN | 271 | Q9H5Z6 | |
| PASTNRDTVESTRTR | 1151 | Q9Y2H6 | |
| SFQITSEVQSGRSPR | 531 | P51841 | |
| FPSSEIQRLREQNTS | 516 | Q2TAC2 | |
| PTESTDNRRVVQRSS | 1131 | Q04637 | |
| LSNRQVSSPSFTNRR | 416 | Q86V48 | |
| NSERVVSSQRPFQES | 256 | Q9H992 | |
| PFQESSDNEGRRTTR | 266 | Q9H992 | |
| SQSPENESNDRRSRR | 516 | Q03164 | |
| RSSNSREQLDQVPSR | 3196 | Q9NYQ7 | |
| NERSSSRINIPERAS | 46 | Q5XKR9 | |
| TFQTQRLLDRSPSRS | 296 | O76039 | |
| QRRNSNPSAESVSAR | 1341 | D6RIA3 | |
| QSQSRSPKRDTTRES | 861 | Q99590 | |
| PSTDRINVTSNARRS | 186 | Q9BY12 | |
| GPETSRRRNVTFSQQ | 501 | Q9Y2W3 | |
| VRSESQERPGSRNSS | 86 | Q659C4 | |
| ETRQSNSARLFVSDP | 206 | O60469 | |
| SENSRSVAATIPRRN | 376 | Q9UQC2 | |
| RRRPCVQQSLSSSFT | 151 | Q2TAK8 | |
| SNDSPRRSFTTEKRN | 26 | Q9NP81 | |
| DRDSSQPRRTIARQT | 51 | Q7Z5A7 | |
| SPRDQQSSSSERGSR | 2706 | Q9UQ35 | |
| RSQIRSRTPSASNDD | 296 | O43765 | |
| TSERFRTQPITSAER | 651 | O95425 | |
| RTNRASAVARTSAPE | 21 | Q96HE8 | |
| TAEEKVSPRTRRQSN | 3616 | Q8NF91 | |
| SQFDTRFTRQTPVDS | 356 | Q9UBS0 | |
| AAPATRVTRRSTQES | 316 | Q15345 | |
| SETSEQPRYRRRTQS | 541 | O60331 | |
| RANSTESVRNTPSTD | 1296 | Q92859 | |
| QQRSTSPVARRTRSQ | 186 | Q9Y252 | |
| SPVARRTRSQTSVNF | 191 | Q9Y252 | |
| SQRESRPVQQTTRRS | 326 | Q9Y252 | |
| LRSQSTFQLSSEPER | 886 | Q8TF72 | |
| SSPNRTTQRENSRTS | 391 | Q9H2D6 | |
| RASRTSSPNRATRDN | 511 | Q9H2D6 | |
| RTTQQDSPRTSCARR | 641 | Q9H2D6 | |
| SESPNSFLDQESRRR | 381 | G9CGD6 | |
| SESPNSFLDQESRRR | 381 | Q6P9H4 | |
| SQLRSSNRRFSIPES | 306 | Q9Y572 | |
| SVDVLNTTPRRSRQT | 686 | Q8WWL2 | |
| SESTSARPSRSERNS | 181 | Q9NVW2 | |
| ARPSRSERNSTEALT | 186 | Q9NVW2 | |
| RDSIASRTRSRSQTP | 336 | Q9NVW2 | |
| SRTRSRSQTPNNTVT | 341 | Q9NVW2 | |
| VRANATRAPRSSSQE | 1136 | Q7Z6L1 | |
| RVTPDRSQTSQDLFS | 1221 | Q9BX66 | |
| SPSETRRERAFDANT | 96 | O15344 | |
| VRSQTLPRTSEAQAR | 301 | Q2TAL5 | |
| ARVQRQITEPTSSTR | 156 | Q6XYQ8 | |
| SRQSSSPEFRVQSFS | 731 | Q9NS56 | |
| SPEFRVQSFSERTNA | 736 | Q9NS56 | |
| EALSSRPFRNVSRQT | 1266 | Q9UPU5 | |
| SPSERNRRVNSDLVT | 76 | H3BQB6 | |
| PFVRSVQRQSLSSRS | 836 | Q70CQ4 | |
| PSVDESFRQSRSNLT | 361 | Q58DX5 |